Development and Validation of an Easy-to-Use Risk Scoring System for Screening High-Risk Varices in Patients with HBV-Related Compensated Advanced Chronic Liver Disease
Authors:
Open Access
- 12 January 2021
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 66 (12) , 4518-4524
Abstract
Background A large portion of patients with compensated advanced chronic liver disease (cACLD) do not have varices or only have low risk varices. Aims To create and validate an easy-to-use risk scoring system to identify high-risk varices (HRV) and spare esophagogastroduodenoscopy (EGD) in patients with hepatitis B virus (HBV)-related cACLD. Methods In total, 334 patients with HBV-related cACLD who had undergone routine laboratory tests and ultrasound examination were enrolled. Multivariate logistic regression analysis was used to determine which variables were the independent risk factors for the presence of HRV, so as to establish the scoring system for screening HRV. The criteria were tested in a training cohort with 221 patients and validated in a validation cohort with 113 patients. Results In the training cohort, the prevalence of HRV was 29.5%. Albumin (ALB) [OR 0.83; 95% confidence index (CI) 0.77–0.90; P < 0.0001], platelet count (PLT) (OR 0.96, 95% CI 0.96–0.99; P < 0.0001) and portal vein diameter (OR 1.40; 95% CI 1.15–1.71; P = 0.001) were independent risk factors for the presence of HRV. The negative predictive value was > 95%, when albumin-platelet-portal vein diameter varices scores (APP score) were < 0.24. One hundred twenty-five of 221 (56.6%) patients met an APP score < 0.24 with a 4.8% HRV miss rate. In the validation cohort, 59 of 113 (51.3%) patients met the APP score < 0.24 with a 1.7% HRV miss rate. Conclusions APP score is a potential model for safely screening HRV and sparing EGDs in patients with HBV-related cACLD.Keywords
Funding Information
- West China Hospital, Sichuan University (No. 2019HXBH045)
- 1·3·5 project for disciplines of excellence–Clinical Research Incubation Project, West China Hospital, Sichuan University. (No. 2019HXFH055)
This publication has 23 references indexed in Scilit:
- Expanding consensus in portal hypertensionJournal of Hepatology, 2015
- Prediction of oesophageal variceal bleeding by measuring spleen stiffness in patients with liver cirrhosisGut, 2015
- Albumin and magnetic resonance imaging-liver volume to identify hepatitis B-related cirrhosis and esophageal varicesWorld Journal of Gastroenterology, 2015
- Prediction of liver cirrhosis, using diagnostic imaging toolsWorld Journal of Hepatology, 2015
- A validated clinical tool for the prediction of varices in PBC: The Newcastle Varices in PBC ScoreJournal of Hepatology, 2013
- Management of Varices and Variceal Hemorrhage in CirrhosisNew England Journal of Medicine, 2010
- Duplex Doppler Ultrasound Examination of the Portal Venous System: An Emerging Novel Technique for the Estimation of Portal Vein PressureDigestive Diseases and Sciences, 2009
- Portal Hypertension and Gastrointestinal BleedingSeminars in Liver Disease, 2008
- Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic databaseGastrointestinal Endoscopy, 2007
- Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?Gut, 2005